엔젠바이오: directors' dealings · South Korea · DART (FSS)

Explore the full directors' dealings record of 엔젠바이오, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Market capitalisation: €36.6bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 에스에이치헬스케어투자1호조합. Every trade is free.